83 related articles for article (PubMed ID: 24785216)
1. Genotype-guided dosing of vitamin K antagonists.
Pereira NL; Rihal CS; Weinshilboum RM
N Engl J Med; 2014 May; 370(18):1762. PubMed ID: 24785216
[No Abstract] [Full Text] [Related]
2. Genotype-guided dosing of vitamin K antagonists.
Schwarz UI; Kim RB; Tirona RG
N Engl J Med; 2014 May; 370(18):1761-2. PubMed ID: 24785215
[No Abstract] [Full Text] [Related]
3. Genotype-guided dosing of vitamin K antagonists.
Cavallari LH; Kittles RA; Perera MA
N Engl J Med; 2014 May; 370(18):1763. PubMed ID: 24785218
[No Abstract] [Full Text] [Related]
4. Genotype-guided dosing of vitamin K antagonists.
Koller EA; Roche JC; Rollins JA
N Engl J Med; 2014 May; 370(18):1761. PubMed ID: 24785214
[No Abstract] [Full Text] [Related]
5. Genotype-guided dosing of vitamin K antagonists.
Kimmel SE; French B; Geller NL;
N Engl J Med; 2014 May; 370(18):1763-4. PubMed ID: 24785213
[No Abstract] [Full Text] [Related]
6. Genotype-guided dosing of vitamin K antagonists.
Daneshjou R; Klein TE; Altman RB
N Engl J Med; 2014 May; 370(18):1762-3. PubMed ID: 24785217
[No Abstract] [Full Text] [Related]
7. Genotype-guided dosing of vitamin K antagonists.
Maitland-van der Zee AH; de Boer A; Manolopoulos VG;
N Engl J Med; 2014 May; 370(18):1765-6. PubMed ID: 24804306
[No Abstract] [Full Text] [Related]
8. Genotype-guided dosing of vitamin K antagonists.
Pirmohamed M; Wadelius M; Kamali F;
N Engl J Med; 2014 May; 370(18):1764-5. PubMed ID: 24804303
[No Abstract] [Full Text] [Related]
9. Do pharmacogenetics have a role in the dosing of vitamin K antagonists?
Furie B
N Engl J Med; 2013 Dec; 369(24):2345-6. PubMed ID: 24251364
[No Abstract] [Full Text] [Related]
10. Warfarin dosing by genotype did not improve time in therapeutic range.
Dunn A
Ann Intern Med; 2014 Mar; 160(6):JC8. PubMed ID: 24638186
[No Abstract] [Full Text] [Related]
11. Pharmacogenetics and coumarin dosing--recalibrating expectations.
Zineh I; Pacanowski M; Woodcock J
N Engl J Med; 2013 Dec; 369(24):2273-5. PubMed ID: 24328463
[No Abstract] [Full Text] [Related]
12. Why admixture matters in genetically-guided therapy: missed targets in the COAG and EU-PACT trials.
Duconge J; Cadilla CL; Seip RL; Ruaño G
P R Health Sci J; 2015 Sep; 34(3):175-7. PubMed ID: 26454897
[No Abstract] [Full Text] [Related]
13. Anticoagulation therapy: genotype-guided anticoagulation therapy-the jury is still out.
Roberts A
Nat Rev Cardiol; 2014 Jan; 11(1):1. PubMed ID: 24302217
[No Abstract] [Full Text] [Related]
14. Using pharmacogenetics in real time to guide therapy: the warfarin example.
Aminkeng F
Clin Genet; 2014 Jun; 85(6):533-4. PubMed ID: 24628520
[No Abstract] [Full Text] [Related]
15. Warfarin pharmacogenetics: to genotype or not to genotype, that is the question.
Cavallari LH; Nutescu EA
Clin Pharmacol Ther; 2014 Jul; 96(1):22-4. PubMed ID: 24942399
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic-based dosing of warfarin.
Med Lett Drugs Ther; 2008 May; 50(1286):39-40. PubMed ID: 18487958
[No Abstract] [Full Text] [Related]
17. Genotype-guided dosing of warfarin.
Mega JL; Giugliano RP
Clin Chem; 2014 Jul; 60(7):920-2. PubMed ID: 24691686
[No Abstract] [Full Text] [Related]
18. Genetic testing for warfarin dosing? Not yet ready for prime time.
Bussey HI; Wittkowsky AK; Hylek EM; Walker MB
Pharmacotherapy; 2008 Feb; 28(2):141-3. PubMed ID: 18225960
[No Abstract] [Full Text] [Related]
19. Genes affecting warfarin response-interactive or additive?
Cavallari LH; Duarte JD
J Clin Pharmacol; 2015 Mar; 55(3):258-60. PubMed ID: 25385663
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the -1639G > A polymorphism of the VKORC1 gene on the dose of oral anticoagulants acenocoumarol, and warfarin in Chilean patients: alternative models of inheritance].
López-Hernández D
Rev Med Chil; 2016 Apr; 144(4):539-41. PubMed ID: 27401392
[No Abstract] [Full Text] [Related]
[Next] [New Search]
